Stock Market News

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments

May 14, 2025 - 12:16
 0
Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments
Read More

Tags:

Previous Article

Septerna stock soars on Novo Nordisk collaboration

Next Article

1 Newly Undervalued Stock for the Month

Related Posts

Coinbase to expand its derivatives offering with $2.9B ...

May 8, 2025  0

US, Russia explore ways to restore Russian gas flows to Europe, sources say

US, Russia explore ways to restore Russian gas flows to...

May 8, 2025  0

Hikma Pharmaceuticals gets 'BBB' rating upgrade from S&P on strong momentum

Hikma Pharmaceuticals gets 'BBB' rating upgrade from S&...

May 8, 2025  0